Medication

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

Readers, including even experts, are falling for a hard sell job by venture capitalists who launder their funding of the…

5 years ago

Is the New York Times a Shill for Promoters of Psychedelics?

Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should…

5 years ago

Blaming the Psychiatric Patient When It’s a Drug-Genetic Interaction

How can patients with psychiatric or any other illnesses be viewed as non-compliant with their medical regimes when there is…

5 years ago

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

Research concerning the role of psychedelics in mental health treatment and its superb publicity campaign depends on millions of dollars…

5 years ago

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

All claims about treatments affecting human health and well-being should be subject to robust review. That review requires someone to…

5 years ago

First Drug Synthesized by AI Goes into Clinical Trials

If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD…

5 years ago

Do Medications Have Psychiatric Side Effects?

Every medication, every procedure, comes with its share of side effects or dangers, some of which are missed by the…

5 years ago

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder…

5 years ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More